You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 151 No. 1, January 1997 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLE
 This Article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Economic impact of pertussis

M. E. Pichichero and J. Treanor
Department of Microbiology and Immunology, University of Rochester Medical Center, NY, USA.

OBJECTIVE: To assess the economic consequences of pertussis in Monroe County, New York (population, 713969), during a 6-year period (1989-1994). METHODS: Cases of pertussis were identified retrospectively by passive reporting and diagnosis based on culture, positive results of direct fluorescent antibody testing, or Centers for Disease Control and Prevention clinical criteria (cough for > 14 days otherwise unexplained or for > 7 days with paroxysms or whoop epidemiologically linked to a laboratory-confirmed case). One hundred seven (50%) of 216 subjects with identified cases of pertussis completed questionnaires and had medical records reviewed to ascertain the costs of illness, including physician office visits, laboratory tests, medications, hospitalization, emergency department visits, additional child care, and lost days from school (children) or from work (parents or adult cases). RESULTS: Ninety-three (87%) of the pertussis case occurred in children. The average duration of illness before diagnosis was 21.3 days (range, 12-37 days). One hundred one patients (94%) saw a physician at least once; overall, the average number of visits per case was 3.2 (range, 1-15). Ninety-seven patients (91%) received at least 1 course of antibiotic therapy (average cost for all antibiotics, $95/case), and all took symptomatic treatment (average cost, $48/case). Fifteen patients (14%) required hospitalization; average cost per admission was $13425 (range, $1732-$69637). Thirty patients (28%) were seen in emergency departments; average cost was $202 (range, $69-$289). Additional child care costs ranged from $12 to $2688. For 50 families, 1 adult lost workdays because of illness or to provide child care for an average of 8.3 days (range, 1-45 days). For 4 families, 2 adults lost an average of 44 days from work (range, 10-120 days). The cumulative number of lost workdays was 758 in association with the 107 cases of pertussis. The average full recovery time from illness was 72.9 days (range, 25-115 days). CONCLUSIONS: Total direct and indirect cost for 107 cases of pertussis in Monroe County was $381052. The economic burden of pertussis is substantial and encourages broader use of vaccination to prevent disease.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Pertussis Vaccination for Health Care Workers
Sandora et al.
Clin. Microbiol. Rev. 2008;21:426-434.
ABSTRACT | FULL TEXT  

IEIIS Meeting minireview: Bordetella evolution: lipid A and Toll-like receptor 4
MacArthur et al.
Innate Immunity 2007;13:243-247.
ABSTRACT  

Rationale for Use of Tdap Booster Vaccines for Adolescent Immunization: Overview of Efficacy, Safety, and Clinical Use
Hitchcock
CLIN PEDIATR 2006;45:785-794.
ABSTRACT  

Acellular Pertussis Vaccine Booster Combined With Diphtheria and Tetanus Toxoids for Adolescents
Pichichero et al.
Pediatrics 2006;117:1084-1093.
ABSTRACT | FULL TEXT  

Relaxed Acyl Chain Specificity of Bordetella UDP-N-acetylglucosamine Acyltransferases
Sweet et al.
J. Biol. Chem. 2002;277:18281-18290.
ABSTRACT | FULL TEXT  

Invited review: The molecular genetics and role in infection of lipopolysaccharide biosynthesis in the Bordetellae
Preston and Maskell
Innate Immunity 2001;7:251-261.
 

Costs of Illness Due to Bordetella pertussis in Families
Lee and Pichichero
Arch Fam Med 2000;9:989-996.
ABSTRACT | FULL TEXT  

Genetic Basis for Lipopolysaccharide O-Antigen Biosynthesis in Bordetellae
Preston et al.
Infect. Immun. 1999;67:3763-3767.
ABSTRACT | FULL TEXT  

Identification and Cloning of waaF (rfaF) from Bordetella pertussis and Use To Generate Mutants of Bordetella spp. with Deep Rough Lipopolysaccharide
Allen et al.
J. Bacteriol. 1998;180:35-40.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1997 American Medical Association. All Rights Reserved.